The information you provide to the chat will be recorded to improve your experience and to contact you. Please read our privacy notice to see how we are processing and protecting your data. Click to view our Cookie Notice.
We'd love your feedback—take a quick survey to help us improve.
How can we help you today?
Search Patheon
Recent searches
Clear History
Suggestions
All Results
Thermo Fisher Scientific
Maximizing pipeline value through integrated drug development: How the Accelerator™ Drug Development model enhances eNPV
White paper
In today’s rapidly evolving biotech and biopharma landscape, bringing a new therapy to market is more complex than ever. Costs are rising, timelines are lengthening, and competition is intensifying—both locally and globally. Yet fragmentation across vendors remains one of the biggest barriers to speed and success.
A new white paper from Thermo Fisher Scientific—validated through independent research by the Tufts Center for the Study of Drug Development—reveals how a fully integrated model uniting CDMO and CRO services can significantly improve expected net present value (eNPV) and speed up drug development timelines.
What you’ll learn:
- The financial impact of integration:
- Discover how unified CDMO and CRO services can add up to $62.9 million in value for monoclonal antibodies and $25.1 million for small molecules in Phase III trials.
- Validated insights from Tufts CSDD:
- Explore real-world data from the first comprehensive study quantifying how integration drives measurable gains in time, cost, and ROI—up to 100x returns.
- Strategic advantages for biotech and biopharma:
- Learn how integration helps emerging biotechs move faster toward funding or acquisition, while enabling global biopharmas to better manage complex portfolios.
- A model built for speed, efficiency, and value:
- See how Accelerator™ Drug Development reduces handoffs, unites data streams, and delivers faster, more predictable outcomes at every stage of development.
Why it matters:
- Every month saved on the drug development journey can represent up to $8 million in additional revenue opportunity.
- The Accelerator™ framework helps you compress timelines, enhance decision-making, and increase long-term pipeline value.
Achieve it all with one partner.
